Literature DB >> 7559917

Staphylococcus aureus Cowan I-induced human immunoglobulin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells.

L M Kozlowski1, S R Kunning, Y Zheng, L M Wheatley, A I Levinson.   

Abstract

Protein A (PA), a cell wall component of SAC, activates human B cells by cross-linking the Fabs of membrane immunoglobulins. Recent data indicate that PA binds only to Fabs that use VH3 heavy chains, and thus it has been designated as a B-cell superantigen. We previously reported that Staphylococcus aureus Cowan I (SAC)-induced IgM rheumatoid factor (RF) by human PBMC was mediated by PA. Therefore, we sought to determine if SAC-induced IgMRF production was confined to PA-binding B cells and if these B cells were enriched for the expression of VH3 heavy chains. We observed that the elicitation of IgMRF in response to SAC was limited to a subset of B cells that bind PA and that this subset was enriched for VH3 mRNA expression. Taken together, these results suggest that IgMRFs produced in response to SAC are enriched for usage of VH3 heavy chains. Thus, this SAC-induced autoantibody response appears to represent a new B-cell superantigenic property of PA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7559917     DOI: 10.1007/bf01543106

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  30 in total

Review 1.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

2.  Chemical coupling of proteins to agarose.

Authors:  J Porath; R Axen; S Ernback
Journal:  Nature       Date:  1967-09-30       Impact factor: 49.962

3.  Human monoclonal rheumatoid factors derived from the polyclonal repertoire of rheumatoid synovial tissue: incidence of cross-reactive idiotopes and expression of VH and V kappa subgroups.

Authors:  K M Thompson; I Randen; J B Natvig; R A Mageed; R Jefferis; D A Carson; H Tighe; O Forre
Journal:  Eur J Immunol       Date:  1990-04       Impact factor: 5.532

4.  Rheumatoid factor secretion from human Leu-1+ B cells.

Authors:  R R Hardy; K Hayakawa; M Shimizu; K Yamasaki; T Kishimoto
Journal:  Science       Date:  1987-04-03       Impact factor: 47.728

5.  Prominent IgM rheumatoid factor production by human cord blood lymphocytes stimulated in vitro with Staphylococcus aureus Cowan I.

Authors:  A I Levinson; N F Dalal; M Haidar; L Tar; M Orlow
Journal:  J Immunol       Date:  1987-10-01       Impact factor: 5.422

6.  Human IgA and IgG F(ab')2 that bind to staphylococcal protein A belong to the VHIII subgroup.

Authors:  E H Sasso; G J Silverman; M Mannik
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

7.  Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies.

Authors:  J H Antin; S G Emerson; P Martin; N Gadol; K A Ault
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

8.  Interaction of human polyclonal IgE and IgG from different species with protein A from Staphylococcus aureus: demonstration of protein-A-reactive sites located in the Fab'2 fragment of human IgG.

Authors:  M Inganäs; S G Johansson; H H Bennich
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

9.  Staphylococcus aureus Cowan I. Potent stimulus of immunoglobulin M rheumatoid factor production.

Authors:  A I Levinson; L Tar; C Carafa; M Haidar
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

10.  The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A.

Authors:  J L Hillson; N S Karr; I R Oppliger; M Mannik; E H Sasso
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  7 in total

1.  Crystal structure of a Staphylococcus aureus protein A domain complexed with the Fab fragment of a human IgM antibody: structural basis for recognition of B-cell receptors and superantigen activity.

Authors:  M Graille; E A Stura; A L Corper; B J Sutton; M J Taussig; J B Charbonnier; G J Silverman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  Staphylococcus aureus isolates from patients with Kawasaki disease express high levels of protein A.

Authors:  E R Wann; A P Fehringer; Y V Ezepchuk; P M Schlievert; P Bina; R F Reiser; M M Höök; D Y Leung
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  scFv-based "Grababody" as a general strategy to improve recruitment of immune effector cells to antibody-targeted tumors.

Authors:  Zheng Cai; Ting Fu; Yasuhiro Nagai; Lian Lam; Marla Yee; Zhiqiang Zhu; Hongtao Zhang
Journal:  Cancer Res       Date:  2013-02-08       Impact factor: 12.701

4.  CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences.

Authors:  R Pospisil; M G Fitts; R G Mage
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

5.  Death by a B cell superantigen: In vivo VH-targeted apoptotic supraclonal B cell deletion by a Staphylococcal Toxin.

Authors:  Carl S Goodyear; Gregg J Silverman
Journal:  J Exp Med       Date:  2003-04-28       Impact factor: 14.307

6.  Antibodies and superantibodies in patients with chronic rhinosinusitis with nasal polyps.

Authors:  Jiun-Bo Chen; Louisa K James; Anna M Davies; Yu-Chang Bryan Wu; Joanne Rimmer; Valerie J Lund; Jou-Han Chen; James M McDonnell; Yih-Chih Chan; George H Hutchins; Tse Wen Chang; Brian J Sutton; Harsha H Kariyawasam; Hannah J Gould
Journal:  J Allergy Clin Immunol       Date:  2016-09-19       Impact factor: 10.793

7.  The effect of pneumococcal immunization on total and antigen-specific B cells in patients with severe chronic kidney disease.

Authors:  Gabrielle Nicole Gaultier; William McCready; Marina Ulanova
Journal:  BMC Immunol       Date:  2019-11-12       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.